Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 23;15(1):14200.
doi: 10.1038/s41598-025-99367-0.

A low-power approach to optical glucose sensing via polarisation switching

Affiliations

A low-power approach to optical glucose sensing via polarisation switching

Ehsan Hassanpour et al. Sci Rep. .

Abstract

High-precision polarimetry is crucial for sensing and imaging applications, particularly for glucose monitoring within the physiological range of 50 to 400 mg/dl. Traditional approaches often rely on polarisation modulation using magneto-optic or liquid crystal modulators, which require high voltages or currents, limiting their practicality for wearable or implantable devices. In this work, we propose a polarisation-switching technique that alternates between two discrete polarisation states, offering a low-power alternative with miniaturisation potential. Using this method, we achieved a Mean Absolute Relative Difference of 7.7% and a Standard Error of Prediction of 9.6 mg/dl across the physiological glucose range, comparable to commercial continuous glucose monitors. Our approach demonstrates a limit of detection of approximately 40 mg/dl, with measurements performed in phosphate-buffered saline spiked with glucose. This work establishes polarisation switching as a viable alternative for glucose sensing, providing a foundation for future development of wearable and implantable glucose monitoring systems. By eliminating power-intensive components, our approach addresses key limitations of traditional polarimetric methods, paving the way for more accessible and energy-efficient diabetes management technologies.

Keywords: CGM; Glucose sensing; Optical biosensor; Polarimetry; Polarisation switching.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Schematics of the experimental setup. A green diode laser (532 nm) served as the light source, which is linearly polarised using a Glan-Thompson polariser (LP). The beam is split into two arms by a 50:50 non-polarising beamsplitter (BS). Polarisation modulation is achieved by linear polarisers set to formula image (formula image). The modulated beams are recombined using a second beamsplitter and pass through the sample cuvette. The transmitted light is analysed using another linear polariser (LP) and detected by a photodiode (PD). Additional components include mirrors (M), a neutral density filter (ND), and a lens (L) for alignment, intensity control, and focusing.
Fig. 2
Fig. 2
(a) Sample waveform recorded for 49.0 and 401.7 mg/dl glucose solutions. (b) Corresponding Fast Fourier Transform (FFT) plot. For clarity, only a selected section of the waveform and its corresponding FFT are displayed.
Fig. 3
Fig. 3
Glucose dependence extracted from the sum of odd harmonic intensities up to formula image. The linear fit achieves an formula image of 0.95 with an SEP of 26.37 mg/dl (x-error). The error bars in the y-axis represent the standard deviation of 15 independent measurements.
Fig. 4
Fig. 4
Ratio of the DC component of the measured signal to the sum of odd harmonics as a function of glucose concentration. Each data point represents the average of 15 independent measurements, with y-errors indicating the standard deviation. The data (black dots) is fitted using the non-linear equation, achieving a fit quality of 0.997.

Similar articles

References

    1. Federation, I. D. IDF Diabetes Atlas 2021. https://diabetesatlas.org/atlas/tenth-edition/ (2021). [Online; accessed 28-12-2021].
    1. Gregory, G. A. et al. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: A modelling study. Lancet Diabetes Endocrinol.10, 741–760. 10.1016/S2213-8587(22)00218-2 (2022). - PubMed
    1. Bommer, C. et al. Global economic burden of diabetes in adults: Projections from 2015 to 2030. Diabetes Care41, 963–970. 10.2337/dc17-1962 (2018). - PubMed
    1. Arokiasamy, P., Salvi, S. & Selvamani, Y. Global Burden of Diabetes Mellitus 1–44 (Springer International Publishing, Cham, 2020).
    1. Sarwar, N. et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet375, 2215–2222. 10.1016/S0140-6736(10)60484-9 (2010). - PMC - PubMed

MeSH terms